
Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
Check price for EmbodyOn Embody's site · partner link
Comparison · updated November 5, 2026
Embody and PeterMD differ in what you pay. Compounded medicines are not FDA-approved.

Compounded semaglutide · 12-month plan · $588 up front · checked Oct 27
Check price for EmbodyOn Embody's site · partner link
$447 total for 10 to 12 weeks · checked Sep 3
Check price for PeterMDOn PeterMD's site · partner link
Both are starting prices, so the plans below show what you would actually pay.
Embody and PeterMD pay us a commission when you join through our links. That never changes a score, an order or a fact on this page. How we make money
Short answer: Embody and PeterMD differ in what you pay, so the plans below decide it.
Embody is best for
People comfortable prepaying a yearly compounded-injection plan who want to compare its full cost with a smaller one-month commitment.
PeterMD is best for
Budget-conscious users looking for the lowest monthly GLP-1 cost.
The available assessments do not establish a score winner, so choose by the medicine, total cost and care you need.
| Embody | PeterMD | |
|---|---|---|
| Price | from $49/mo | from $149/mo |
| Medicine | BothCompounded only | |
| Needle-free option | BothNot listed | |
| Insurance | BothNo insurance listed | |
| Consultation | BothIncluded | |
| Shipping | Free | Included |
| Where it ships | 49 states plus DC, all except Louisiana | All states except AL, ID, AK and HI on the GLP1 plus B12 program and AL and ID on the tirzepatide page, while the intake form asks instead about Alabama, Arkansas, Idaho and Hawaii, so verify your state at signup |
| Trustpilot | 3.8 / 5 across 10,100 reviews | Not tracked |
| BBB rating | D+ (not accredited) | A+ (accredited since August 10, 2026) |
| Our score | 7.6/10 Good | 6.5/10 Fair |
| Assessment limits | Checked Oct 16, 2026; a rating claim didn't match Trustpilot. | Checked Oct 16, 2026; few independent reviews yet. |
Four published plan lengths for each injection. A sale advertised October 27 through December 1, 2026 cut the twelve-month prepaid amounts to $588 for semaglutide and $1,188 for tirzepatide; one-month plans stayed at $79 and $129.
Payments are normally non-refundable; a limited medical-disqualification exception applies.
The October 27–December 1, 2026 sale offers semaglutide at $49/month equivalent ($588 prepaid for twelve months) and tirzepatide at $99/month equivalent ($1,188 prepaid). One-month plans remain $79 and $129. The published terms say the rate stays fixed on the selected plan. Confirm the renewal amount and date before paying; these sale rates are not month-to-month bills.
We checked Embody's prices on October 27, 2026.Every Embody price and plan
Embody’s GLP-1 website is joinem.co. GLP-1 Picks is an independent comparison site.
Want Embody on its own? Read our Embody GLP-1 review to see what you pay for semaglutide or tirzepatide and what customer reviews say, or check is Embody legit for its BBB, Trustpilot and FDA records.
Two compounded programs at two prices: GLP1 plus B12 from $149/mo, and tirzepatide plus B12 at $209/mo for any dose, with the page stating the price does not rise as your dose increases.
The GLP1 plus B12 product page prices Level 1 at "$149/Month" and "$447 Total" for an estimated 10 to 12 week supply. Level 2 is labelled "$139/Month" and "$834 Total" for an estimated 8 to 12 week supply for current or returning users. These monthly labels and totals do not establish a monthly supply or when the next charge occurs. The separate tirzepatide plus B12 program advertises $209/mo for any dose with $100 off month one, and the tirzepatide page quotes $149 to start and $249 per month after that, billed quarterly at 60mg (verified 2026-09-03)
We checked PeterMD's prices on September 3, 2026.
Strengths
More to watch for
Strengths
More to watch for
Compounded medicines are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are sold. Read the FDA's explanation of the risks.
At least one headline price is a starting, introductory, prepaid or partial figure, so neither is simply cheaper.
Neither wins outright on our scores, so the better one is the one that fits your medicine, budget and care needs.
Embody and PeterMD both list compounded medication.
Neither Embody nor PeterMD lists insurance support.
Embody:prices checked October 27, 2026, score evidence assessed October 16, 2026.Read our Embody review
PeterMD:prices checked September 3, 2026, score evidence assessed October 16, 2026.Read our PeterMD review
We score on a published methodology, and partnership never changes a score or a fact here.
Before you sign up, read our trust check: is Embody legit.